期刊文献+

帕金森病大鼠黑质致密部IgG蛋白的表达变化 被引量:1

Changes of IgG expression in substantia nigra par compacta of Parkinson's disease rats models
下载PDF
导出
摘要 目的研究帕金森病(Parkinson disease,PD)模型大鼠黑质致密部免疫球蛋白G(immunoglobulin G,IgG)的表达变化,探讨其在PD发病中的作用。方法经单侧微量注射神经毒素6-羟多巴胺(6-hydroxydopamine,6-OHDA)制备PD大鼠模型。采用免疫组化方法检测对照组大鼠双侧、模型组大鼠健侧及损毁侧黑质致密部酪氨酸羟化酶(tyrosine hydroxylase,TH)阳性神经元、IgG阳性细胞数目及积分光密度值(integrated option density,IOD)比值的变化。结果模型组PD大鼠损毁侧TH阳性神经元数量较健侧明显减少(P<0.01),正常组大鼠和模型组大鼠黑质致密部均有IgG阳性细胞存在,但是模型组大鼠损毁侧致密部IgG阳性细胞数量明显增加(P<0.01),染色深。结论 PD大鼠黑质致密部细胞IgG蛋白表达增加,表明IgG参与了PD的发生。 Objective To investigate the changes of immunoglobulin G (IgG) expression in substantia nigra par compacta of Parkinson' s disease (PD) rat models,and to explore the role of IgG in the pathophysiology mechanism of PD.Methods PD rat models were established by microinjection of 6-hydroxydopamine (6-OHDA) solution into the substantia nigra of the right side of the rat brain.Fifteen PD rats served as the model group and 5 adult normal rats were injected with saline instead of 6-OHDA as the control group.The expression of tyrosine hydroxylase (TH) positive neurons,the number of IgG positive cells,and the integrated option density (IOD) ratios of substantia nigra par compacta of rats in the two groups were examined by immunohistochemical methods.Results There were only a few TH positive cells in the lesioned side of the model group.The differences between the ratios of the TH-positive cells of lesioned side to the normal side in the model group and to the both sides in the control group were significant,respectively (P<0.05).There were many IgG positive cells in substantia nigra par compacta in the normal group and model group.However,there were more IgG positive cells in the lesioned side of the model group,and the differences between the ratios of the IgG positive cells of the lesioned side to the normal side in the model group and to the both sides in the control group were significant,respectively (P<0.05).Conclusions There exists IgG positive cells in substantia nigra par compacta,and the expression of IgG significantly increased in PD rat models in the lesioned side.
出处 《中国神经免疫学和神经病学杂志》 CAS 北大核心 2014年第1期20-23,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 山东省高等学校科技计划项目(J13LK51)
关键词 帕金森病 酪氨酸单氧化酶 免疫球蛋白G 黑质 Parkinson's disease tyrosine 3-monooxygenase immunoglobulin G substantia nigra
  • 相关文献

参考文献11

  • 1More SV, Kumar H, Kim IS, et al. Cellular and molecular mediators of neuroin{lammation in the pathogenesis of Parkin- son's disease. Mediators Inflamm, 2013, 2013: 952375.
  • 2汪锡金,陈生弟,刘卫国,陆国强,梁梁,徐洁懿.帕金森病IgG诱导多巴胺能神经元损伤机制的初步研究[J].中华神经科杂志,2004,37(4):335-339. 被引量:4
  • 3Huang J, Sun X, Mao Y, et al. Expression of immunoglobu lin gene with classical V-(D)-J rearrangement in mouse brain neurons. Int J Biochem Cell Biol, 2008, 40: 1604-1615.
  • 4Niu N, Zhang J, Guo Y, et al. Expression and distribution of immunoglobulin G and its receptors in the human nervous sys tern . Int J Biochem Cell Biol, 2011, 43: 556-563.
  • 5Pellegrino LJ,Pellegrino AS,Cushman AJ. A stereotaxic atlas of the rat brain[M]. 2 nd ed. Plenum press,1979.
  • 6Arumugam TV, Tang SC, Lathia JD, et al. Intravenous im- munoglobulin(IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death [J]. Proc Natl Acad Sci USA, 2007, 104: 14104-14109.
  • 7Fehlings MG, Nguyen DH. Immunoglobulin G: a potential treatment to attenuate neuroinflammation following spinal cord injury[J]. J Clin Immunol, 2010, 30 (Suppl 1): S109- Sl12.
  • 8Le WD, Rowe DB, Jankovic J, et al. Effects of cerebrospinal fluid from patients with Parkinson's disease on dopaminergic cells[J]. ArchNeurol, 1999, 56: 194-200.
  • 9Wang XJ, Yan ZQ, Lu GQ, et al. Parkinson disease IgG and C5a-induced synergistic dopaminergic neurotoxicity: Role of microglia [J]. Int Neuroehem, 2007, 50: 39-50.
  • 10Benkler M, Agmon-Levin N, Hassin Baer S, et al. Immunol- ogy, Autoimmunity, and Autoantibodies in Parkinson's Disease[J]. Clin Rev Allergy Immunol, 2011, 42:164-171.

二级参考文献17

  • 1Rowe DB, Le WD, Smith RG, et al. Antibodies from patients with Parkinson's disease react with protein modified by dopamine oxidation. J Neurosci Res, 1998, 53:551-558.
  • 2Bonnie MB, William PK, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J Exp Med, 1998,188:431-438.
  • 3Jauneau AC, Ischenko A, Chan P, et al. Complement component anaphylatoxins upregulate chemokine expression by human astrocytes. FEBS Lett, 2003,537: 17-22.
  • 4McGeer PL, McGeer EG. Autotoxicity and Alzheimer disease. Arch Neurol, 2000,57:789-790.
  • 5Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther, 2003,304:1-7.
  • 6Gao HM, Hong JS, Zhang W, et al. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci, 2003,23:1228-1236.
  • 7Chen SD, Le WD, Xie WJ, et al. Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins.Arch Neurol, 1998,55: 1075-1080.
  • 8Le WD, Rowe DB, Xie W, et al. Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease. J Neurosci, 2001,21:8447-8455.
  • 9Gao HM, Jiang JW, Wilson B, et al. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson' s disease. J Neurochem, 2002,81:1285-1297.
  • 10Gao HM, Hong JS, Zhang WQ, et al. Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease. J Neurosci, 2003,23:1228-1236.

共引文献3

同被引文献15

  • 1Nolan YM,Sullivan AM,Toulouse A.Parkinson’s disease in the nuclear age of neuroinflammation[J].Trends Mol Med,2013,19:187-196.
  • 2Taylor JM,Main BS,Crack PJ.Neuroinflammation and oxidative stress:co-conspirators in the pathology of Parkinson’s disease[J].Neurochem Int,2013,62:803-819.
  • 3More SV,Kumar H,Kim IS,et al.Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson’s disease[J].Mediators Inflamm,2013,2013:952375.
  • 4Benkler M,Agmon N,Hassin S,et al.Immunology,Autoimmunity,and Autoantibodies in Parkinson’s disease[J].Clin Rev Allergy Immunol,2012.42:164-171.
  • 5Ha D,Stone DK,Mosley RL,et al.Immunization strategies for Parkinson’s disease[J].Parkinsonism Relat Disord,2012,18:S218-221.
  • 6Huang J,Sun X,Mao Y,et al.Expression of immunoglobulin gene with classical V-(D)-J rearrangement in mouse brain neurons[J].Int J Biochem Cell Biol,2008,40:1604-1615.
  • 7Niu N,Zhang J,Guo Y,et al.Expression and distribution of immunoglobulin G and its receptors in the human nervous system[J].Int J Biochem Cell Biol,2011,43:556-563.
  • 8Nagele EP,Han M,Acharya NK,et al.Natural Ig G autoantibodies are abundant and ubiquitous in human sera,and their number is influenced by age,gender,and disease[J].PLo S One,2013,8:e60726.
  • 9Orr CF,Rowe DB,Mizuno Y,et al.Possible role for humoral immunity in the pathogenesis of Parkinson’s disease[J].Brain,2005,128:2665-2674.
  • 10Sanchez-Guajardo V1,Annibali A,Jensen PH,et al.α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model[J].J Neuropathol Exp Neurol,2013,72:624-645.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部